2022”N10ŒŽ27“ú

‰¤’©‚Í–Å‚Ñ‚é

u‹{ú±Žs’è‘SW@‚P‚Ov‘v@Šâ”g‘“X@‚P‚X‚X‚Q”N

“ì‘v‚Ì–Å–S@p‚X‚R`

@uæɎ—“¹i‚©‚¶‚Ç‚¤j‚ª—@‚É—p‚¢‚ç‚ê‚Ä•_“°‚É—§‚¿‚½‚é“–‰‚̐­Ž¡‚́AŠm‚©‚É‘å‚¢‚ÉŒ©‚é‰Â‚«‚à‚Ì‚ª‚ ‚Á‚½B@æɎ—“¹‚Í›Š¯‚̐ꉡ‚𐧂µAŠOÊ‚Ìæë绂ð—}‚¦AŠ¯—™‚̗Š¯‰^“®‚ð••‚¶A‰ïŒvŒŸ¸‚ðŒµd‚É‚µ‚āAŒRŽ–”ï‚ÌŽU–ŸŽxo‚ð‹Ö‚¶‚½B@Žê‚É‚Æ‚©å–W‚·‚éŠw¶ŒQ‚ÌŒy‹“–Ï“®‚·‚é‚Ì‚ð’eˆ³‚µ‚āAŽŠ‚鏊‚ÉáÉ‚Ý‚ð‚«‚©‚¹A“eŠp—D_‚Ȃ闝@‚̐e­‚̊ԁA•ú–Ÿ‚É—¬‚ꂽ‚é’©’ì‚Ì‹Ij‚ðUl‚µ‚½B@”Þ‚Í–”ˆê•û‚ɐl‹CŽæ‚萭ô‚Æ‚µ‚āAŽéŽqŠwŽÒ‚Ì–„‚à‚ꂽ‚éŠwŽÒ‚ð“o—p‚µ‚Ä’©’ì‚É—§‚½‚¹A”Þ“™‚Ì–³”\‚È‚é‚ɏ悶‚āAŽÀŒ ‚ðŽ©ŒÈ‚ÌŽè‚ɏ¶ˆ¬‚µ‚½B

@”Þ‚ÌŒoÏà­ã‚ɉ—‚¢‚ÄŽŽ‚Ý‚½‚éŒö“c‚̐ݒu‚Í’–Ú‚É’l‚·‚éB@—}‚à“ì‘v‚ɉ—‚¢‚č‘‰Æà­‚̍łàd—v‚È‚éŽxo‚ÍŒR‘à‚Ì‹‹—^‚Å‚ ‚èAŒR—Æ‚Í‘dÅ‚̏ã”[‚Ì‚Ý‚Å‚Í•s‘«‚Å‚ ‚Á‚½‚̂ŁA˜aâùi‚í‚Ä‚«j‚Æ‚¢‚¤•û–@‚É‚æ‚èA–¯ŠÔ‚æ‚è•Ä‚𔃂¢ã‚®‚é‚Ì‚Å‚ ‚邪A‚»‚ÌŽx•¥‚¢‚É‚Í‘½‚­‰ïŽq*‚ðˆÈ‚Ä‚µA”V‚ª‰ïŽq—””­‚ÌŽ~‚ß‚ñ‚Æ‚µ‚ÄŽ~‚Ü‚é”\‚í‚´‚錴ˆö‚Å‚ ‚Á‚½B@˜¹i‚æj‚Á‚ÄæɎ—“¹‚͘aâù‚ð‚¹‚¸‚µ‚ÄŒR—Æ‚Ì‹Ÿ‹‹‚ÉŽ–Œ‡‚©‚´‚é‚悤A—ÕˆÀ‚É‹ß‚«Ÿ´¼È‚Ì‘å’nŽå‚̏Š—L’n‚ð‹­§“I‚ÉŽOŠ„’ö‚𐭕{‚É”ƒ‚¢ã‚°‚ÄŒö“c‚Æ‚µA‚»‚Ì”Nv•Ä‚ðˆÈ‚ÄŒR‘à‚É‹Ÿ‹‹‚·‚éŒv‰æ‚𗧂Ă½B@Œö“c‚Ì”ƒŽû‚É“–‚½‚Á‚Ä‚Í‘Š“––¯ŠÔ‚É”½‘΂̐º‚ð•·‚¢‚½‚ª’fŒÁ‚Æ‚µ‚Ä“y’n”ƒã‚ð‹­s‚µAŽO•SŒÜ\–œ¤‚ÌŒö“c‚𓾂āA—¼Ÿ´‚̘aâù‚ð”ë‚ß‚Ä‚à¢‚ç‚Ê’ö“x‚ÉŽŠ‚Á‚½‚Ì‚ðŒ©‚é‚ƁA”ނ̍˔\‚ª•ÀX‚Å‚Í‚È‚©‚Á‚½‚±‚Æ‚ª‚í‚©‚éB

@Œi’àŒÜ”N—@ˆ·‚µ‚ÄŽq“x@i‚½‚­‚»‚¤jŽk‚¬AæɎ—“¹‚ÌŒ —͉͂vX‰Á‚í‚èA鰍‘Œö‚É••‚º‚ç‚êA•½ÍŒR‘dŽ–‚Æ‚È‚èA‹‘æ‚𐼌΂̐¼Š‹—ä‚ÉŽ’‚èA\“ú–ˆ‚Ɉ꒩æR‚·‚é‚݂̂ŁAí‚ÉŽ„“@‚É‹‚Á‚Đ­–±‚ðŒˆ‚µ‚½‚̂ŁAŠ†‚à­•{‚ªŠ‹—ä‚Ɉړ]‚µ‚½‚©‚ÌŠÏ‚ª‚ ‚Á‚½B@Ž§‚µ‚Ä“sl‚à–’A•Ó•ñ‚ð•·‚­‚±‚Æ‹H‚ɁAã‰º‘¾•½‚ÉŠµ‚ê‚ĈÀˆí‚ðæÂèAŒÎŽR‚̏Ÿ槩i‚µ‚傤‚ª‚¢j‚ÉŽlŽž—VŠy‚µ‚āA‰Ì•‘’¾çŁAŒŽ“ú‚ð–Y‚é‚é‚ÌŠT‚ª‚ ‚Á‚½B

@Ž§‚à‘vl‘ו½‚Ì–²‚͍š‚¿‚É‚µ‚āA–֌Ðl‚Ì—ˆP‚É‚æ‚Á‚Ä‘Å‚¿”j‚ç‚ꂽB@æ‚ɍš•K—ó‚͐ª‘v‚Ì–ð‚æ‚è‹A‚é‚ƁAŠJ•½‚ɉ—‚¢‚ÄŽ©—§‚µ‚Ä’èˆÊ‚ɂ‚«A‘‚ð‘匳‚ƍ†‚µA”N†‚𒆓‚Æ—§‚Ä”¼‚Î’†‘Ž®‚̐­•{‚ð‰‹ž‚É—§‚Ä‚Ä‘å“s‚Æ‚È‚µA‘“à‚̐®—‚ɂ‚­‚â郝Œoi‚©‚­‚¯‚¢j‚ðŽg‚Æ‚µ‚Ä‘v‚É”hŒ­‚µA¦‚Ä—É‹à‚ª‘v‚æ‚蓾‚½‚éÎ•¼‚ðŠl‚ñ‚±‚Æ‚ð—v‹‚µ˜Ò‚Á‚½B@æɎ—“¹‚Í‚»‚ꂪ“s‰º‚̐lS‚ð“®—h‚¹‚µ‚ß‚ñ‚±‚Æ‚ð‹°‚ê‚āA郝Œo‚ð^B‚ɍS—¯‚µ‚½‚ªAŒ³‚̐¢‘cš•K—ó‚Í–úX‘v‚𕽒肹‚ñ‚ÆŽu‚µA‘v‚ւ̑Ζk–h‰q‹šü‚Ì—vŠAåõ—z‚̍UŒ‚‚𖽂¶‚½‚Ì‚Å‚ ‚éB

@“ì‘v–h‹šü‚̃”ƒFƒ‹ƒ_ƒ“‚½‚éåõ—z‚͍UŒ‚‚ðŽó‚­‚邱‚ƌܔN‚ÌŒã‚ɊחŽ‚µAˆêŠp”j‚ê‚Ä‘Sü–’•Û‚”\‚킸AŒ³«”ŒŠçi‚΂â‚ñj‚ÌŒR‚ÍŠ¿…‚ð‰º‚è‚Ä—gŽq]‚ɏo‚āA—gŽq]‚É‹²‚ñ‚Å“Œ‰º‚·‚ê‚΁A‘v‚Ì“à’n‚Í•—‚ð–]‚ñ‚ō~‚èAæɎ—“¹‚Ì—¦‚¢‚½‚é‘DŽt‚à•“ŒÎ•t‹ß‚ɒׂ¦‚āAŒ³ŒR‚͏@“s—ÕˆÀ‚É”—‚Á‚Ä–³ðŒ~•š‚ðŠ©‚µ‚½B
@•¶“VËA’£¢Œ†A—¤G•v“™‚͍~•š‚ð‹ûi‚¢‚³‚¬‚æj‚µ‚Æ‚¹‚¸A•¶“VË‚Í’E‘–‚µ‚Ä‹`•º‚ð‹“‚°‚½‚ªA‘å™Í‚Ì•¢‚é‚͈ê–Ø‚ÌŽx‚¤‚鏊‚É”ñ‚¸‚µ‚āA‰½’ö‚ÌŒø‰Ê‚à‚È‚©‚Á‚½B’£¢Œ†‚Í‹±’é‚ÌŒZ’í‚ð—i‚µ‚ÄŒR‘D‚ɏæ‚è‚ÄŠCã‚É“¦‚ꂽ‚é‚àAúŽR‚̐킢‚É”j‚ê‚ċ󂵂­“ìŠC‚Ì‘”‹û‚ƏÁ‚¦‹Ž‚Á‚½‚Ì‚Å‚ ‚Á‚½iˆê“ñŽµ‹ã”NjBv

‰ïŽq*@–k‘v‚Ì‚±‚ë‘å“sŽs‚Ì‹à—Z‹ÆŽÒ‚ª”­s‚µ‚½–ñ‘©ŽèŒ`B“ì‘v‚É“ü‚萭•{‚ª”­s‚µA—””­‚µ‚½‚½‚߁A‰¿’l‚ðŽ¸‚Á‚½B


iwŽx“ߐ­Ž¡Žjx‰ºŠªAˆê‹ãŽlˆê”NŽµŒŽj
----


posted by Fukutake at 14:04| “ú‹L

˜V‚¢‚ÄŽ€‚Ê‚±‚Æ

u‚Ü‚½‚½‚ѓǏ‘˜^v@ŒQ‚悤‚±@V’ª•¶ŒÉ@•½¬\ŽO”N

u“èŽRßlv[‘òŽµ˜Y@‚æ‚è@—ՏI‚Ì‚¨Žè–{@p‚U‚Q`

@u[‘òŽµ˜Y‚́u“èŽRßlv‚́A‘§Žq‚ª•êe‚ð”w•‰‚Á‚āAŽR‚É’u‚¢‚Ä‚¢‚­˜b‚Å‚ ‚éB@Ž„‚Í–{‚ð“ǂނ܂ł́AŽ×–‚‚É‚È‚Á‚½•êe‚ðA‘§Žq‚ª‚Þ‚è‚â‚èŽR‚É’u‚¢‚Ä‚¢‚­˜b‚¾‚ÆŽv‚Á‚Ä‚¢‚½B@‚Æ‚±‚낪“Ç‚ñ‚Å‚Ý‚é‚ƁA‚»‚¤‚Å‚Í‚È‚©‚Á‚½B@ŽR‚É’u‚«‹Ž‚è‚É‚³‚ê‚邱‚Æ‚ðA•êe‚ª‹­‚­–]‚ñ‚Å‚¢‚½‚Ì‚Å‚ ‚éB

@•êe‚Å‚ ‚邨‚è‚ñ‚́A‘̂̏ä•v‚ÈŽ©•ª‚ªA”NŠñ‚è‚炵‚­‚È‚¢‚©‚ç‚ƁAŒ™‚Å‚½‚Ü‚ç‚È‚¢B@•n‚µ‚­H—¿‚Ì–R‚µ‚¢‚»‚Ì‘º‚ł́A‘·‚Í‚Æ‚à‚©‚­‘]‘·‚ð•ø‚­‚È‚Ç‚Æ‚¢‚¤’·¶‚«‚È”NŠñ‚è‚Í’p‚Å‚ ‚èA‚¨‚è‚ñ‚̂悤‚ɏä•v‚ÈŽ•‚ðŽ‚Á‚Ä‚¢‚Ä‚àA‰½‚Å‚àH‚ׂ»‚¤‚ÉŽv‚í‚ê‚āA‚±‚ê‚Ü‚½’p‚È‚Ì‚Å‚ ‚éB

@ˆêl‘§Žq‚̉ł́A‹Ž”NAŒI‚ðE‚¢‚ɉ]‚Á‚Ä’J’ê‚É“]‚°—Ž‚¿‚ÄŽ€‚ñ‚¾B@‚È‚ñ‚Æ‚©Œã“Y‚¦‚ð‚ÆŽv‚Á‚Ä‚¢‚½‚ªAŽR‚ÌŒü‚±‚¤‚©‚ç•v‚ÌŽl\‹ã“ú‚ðÏ‚Ü‚¹‚½‚΂©‚è‚́A‹Ê‚â‚ñ‚Æ‚¢‚¤—«‚ª‚â‚Á‚Ä‚«‚½B@ŠÈ’P‚ɐl‚ªÁ‚¦A‚Ü‚½ŠÈ’P‚ɐl‚ª‘‚¦‚é‚Ì‚Å‚ ‚éB

@u‚¨‚΂â‚ñ‚ª‚¢‚¢l‚¾‚©‚çA‘‚­s‚¯v
‚Æ‚¢‚í‚ꂽ‚ƁA‚¨‚è‚ñ‚ɘb‚µ‚½B@‚¨‚è‚ñ‚Í‚Æ‚Á‚Ä‚à‚¤‚ꂵ‚­‚È‚Á‚½B
@\˜ZÎ‚Ì‘·‚É‚à‰Å‚ª‚«‚½B@‰Å‚Æ‚¢‚Á‚Ä‚à‰½‚̎葱‚«‚ª‚ ‚é‚킯‚¦‚à‚È‚­AŸŽè‚É‚â‚Á‚Ä‚«‚ĔтðH‚¢A‘·‚Æ“¯‚¶•z’c‚ŐQ‚Ä‚¢‚邤‚¿‚ɁA‚»‚̂悤‚É”FŽ¯‚³‚ê‚é‚悤‚É‚È‚é‚Ì‚Å‚ ‚Á‚½B@‚¨‚è‚ñ‚ÍŽR‚֍s‚­‚Ì‚ðŠy‚µ‚Ý‚É‚µ‚Ä‚¢‚½‚ªA‘§Žq‚Æ‹Ê‚â‚ñ‚Í‚»‚ê‚ð”ß‚µ‚ª‚éB

u–Ú‚Ì‚ ‚½‚肪Œõ‚Á‚Ä‚¢‚邯‚ǁA—Ü‚Å‚ào‚µ‚Ä‚¢‚é‚ñ‚¶‚á‚Ë‚¦‚ç‚©H@‚»‚ñ‚È‹C‚ÉŽã‚¢‚±‚Æ‚¶‚።‚Á‚½‚à‚Ì‚¾v
@‚»‚¤‚¨‚è‚ñ‚ÍŽv‚¤‚Ì‚¾‚ªA“àS‚»‚Ì‹CŽ‚¿‚ª‚¤‚ꂵ‚­‚à‚ ‚Á‚½B@g“à‚ÉŽc”O‚ª‚ç‚ê‚ÄŽR‚ɍs‚«AŽ©•ª‚͐V‚µ‚¢â¥‚̏ã‚ɁA‚«‚ê‚¢‚ȍª«‚ō¿‚Á‚Ä‚¢‚é‚Ì‚¾‚ƁA‚¨‚è‚ñ‚͐S‚É‚µ‚Á‚©‚茈‚ß‚Ä‚¢‚½‚Ì‚Å‚ ‚éB

@‚¨‚è‚ñ‚Í–]‚Ý’Ê‚èA‚©‚ç‚·‚ª‚½‚­‚³‚ñ‚¢‚éŽR‚É’u‚¢‚Ä‚¢‚©‚ê‚éB@”ß‚µ‚ñ‚Å‚¢‚½‘§Žq‚àA‰Æ‚É–ß‚é‚Æ‹C‚ªŠy‚É‚È‚Á‚½B@‹qŠÏ“I‚É‚Ý‚é‚Ə󋵂͎c“‚¾‚ªA‚¨‚è‚ñ‚Í–]‚ñ‚¾‚Æ‚¨‚è‚̐l¶‚̏I‚í‚è‚ðŒ}‚¦‚ç‚ê‚čK‚¹‚¾‚Á‚½B@”ß‚µ‚¢‚È‚©‚É–¾‚邳‚ª‚ ‚é‚Ì‚ª‹~‚¢‚Å‚ ‚éB

@‘·‚âŽq‚ÉŠÅŽæ‚ç‚ê‚ÄŽ€‚Ê‚Ì‚ªK‚¹‚©Aˆêl‚Å‚Û‚Á‚­‚èÀ‚­‚Ì‚ªK‚¹‚©A‚»‚ê‚͐l‚»‚ꂼ‚ê‚Ì–â‘è‚Å‚ ‚éB@‹ã\˜ZÎ‚Æ‚¢‚Á‚½‚çA\•ª‚Æ‚¢‚Á‚Ä‚à‚¢‚¢”N—‚ªA‚»‚ê‚Å‚à‚à‚¤‚¿‚å‚Á‚Æ’·¶‚«‚µ‚Ä‚­‚ꂽ‚ç‚æ‚©‚Á‚½‚Ì‚É‚ÆŽv‚Á‚½B@g“à‚É‚Í‚Ç‚¤‚µ‚Ä‚à‚ ‚«‚ç‚ß‚«‚ê‚È‚¢‹CŽ‚¿‚ªŽc‚éB@“–l‚ª–]‚ñ‚¾‚Æ‚¨‚è‚É‚È‚Á‚½‚Ì‚¾‚©‚çA‚»‚ꂪ‚¢‚¿‚΂ñ‚æ‚©‚Á‚½‚Ì‚¾‚ƁAŽüˆÍ‚ÌŽÒ‚ÍŽ©•ª‚½‚¿‚ðˆÔ‚߂邵‚©‚È‚¢B@’N‚à‚ªŽ©•ª‚ª–]‚ñ‚¾‚悤‚ɐl¶‚ðI‚¦‚ç‚ê‚é‚킯‚Å‚Í‚È‚¢B@‚»‚ê‚ð‚»‚Ì’Ê‚è‚É‚µ‚½‚È‚ñ‚āA‚»‚ê‚Í–S‚­‚È‚Á‚½‘c•ê‚ªAŽc‚³‚ꂽŽ„‚½‚¿‚ɑ΂µ‚Ä‚µ‚Ä‚­‚ꂽAÅ‚‚ÌŽv‚¢‚â‚肾‚Á‚½Bv

----

posted by Fukutake at 14:00| “ú‹L

“ú–{l‚ÍŠF‰Æ‘°H

uƒzƒ“‚Ì–{‰¹v@ŒQ‚悤‚±@Špì•¶ŒÉ@•½¬ŒÜ”N

@“ú–{l‚ĉ½‚¾@p‚W‚Q`

@uŽ„‚Ì’m‚荇‚¢‚ŁAƒJƒiƒ_l‚ÆŒ‹¥‚µ‚½“ú–{l—«‚ª‚¢‚éBƒJƒiƒ_‚ɏZ‹‚ª‚ ‚é‚Ì‚¾‚ªAæ“ú”ޏ—‚Ì—¢‹A‚è‚ɂ‚«‚ ‚Á‚āA”Þ‚ª“ú–{‚É‚â‚Á‚Ä‚«‚½B“ú–{Œê‚ª‚ЂƂ±‚Æ‚à˜b‚¹‚È‚©‚Á‚½”Þ‚ªA—ˆ“ú‚µ‚Ĉê”ԍŏ‰‚ÉŠo‚¦‚½‚±‚Ƃ΂́uƒIƒoƒ^ƒŠƒAƒ“v‚¾‚Á‚½BƒX[ƒp[ƒ}[ƒPƒbƒg‚âA“dŽÔ‚Ì’†‚Å–ã’…‚ð‹N‚±‚·wƒIƒoƒ^ƒŠƒAƒ“v‚ɔނُ͈í‚È‹»–¡‚ðŽ¦‚·‚悤‚É‚È‚èA–ˆ“úA’¬“à‚ð•à‚«‰ñ‚Á‚Ä‚¢‚éB‚»‚µ‚Ä‹A‚Á‚Ä‚­‚é‚ƁA
uƒLƒ‡ƒEƒ‚AƒIƒoƒ^ƒŠƒAƒ“ƒ’ƒ~ƒ}ƒVƒ^v
@‚Æ‚¤‚ꂵ‚»‚¤‚É•ñ‚·‚é‚Ì‚¾B‚Ó‚½‚è‚ÅŠOo‚µ‚Ä‚àA”ޏ—‚Ì‚Ù‚¤‚̓Iƒoƒ^ƒŠƒAƒ“‚Æ‚Í‚©‚©‚í‚肽‚­‚È‚¢‚̂ɁA”Þ‚Í‚É‚±‚É‚±‚µ‚ăIƒoƒ^ƒŠƒAƒ“‚É‚·‚èŠñ‚Á‚Ä‚¢‚­‚Æ‚¢‚¤‚Ì‚Å‚ ‚éB

@‚±‚̃Iƒoƒ^ƒŠƒAƒ“‚Æ‚¢‚¤‚±‚Ƃ΂́u‚¨‚΂³‚ñv‚©‚琶‚܂ꂽ‚à‚Ì‚¾‚ªAw“ú–{“IŽ©‰äxiŠâ”gV‘j‚É‚æ‚é‚ƁAŽ©•ª‚̐eÊ‚Å‚à‚È‚¢‚̂ɁA’m‚ç‚È‚¢”N’·‚Ì’j«‚⏗«‚ɑ΂µ‚āAu‚¨‚¶‚¢‚³‚ñvu‚¨‚¶‚³‚ñv‚ ‚é‚¢‚́u‚¨‚΂ ‚³‚ñvu‚¨‚΂³‚ñv‚È‚Ç‚Æ‚¢‚¤‚̂́A“ú–{“IƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“‚̂ЂƂ‚̓Á’¥‚ŁA
u–¢’m‚̐l‚ð‰Æ‘°Ae‘°‚ ‚‚©‚¢‚É‚·‚é‚̂́A‹^Ž—‰Æ‘°“I‚ȐlŠÔŠÖŒW‚ð•\Œ»‚·‚é‚‚à‚è‚È‚Ì‚¾‚낤v
@‚Æ‚ ‚éB‚»‚µ‚Ä‚±‚ê‚Í“ú–{l‚̎Љï‘S‘Ì‚ªA‹^Ž—‰Æ‘°“I‚ȏW’c‚Æ‚µ‚Ä‚ÌŠî–{“I‚Ȑ«Ši‚ð‚É‚È‚Á‚Ä‚¢‚é‚©‚炾‚Əq‚ׂĂ¢‚éBŽ„‚à–³ˆÓŽ¯‚Ì‚¤‚¿‚ɔޏ—‚½‚¿‚ðu‚¨‚΂³‚ñv‚ƌĂñ‚Å‚¢‚½B‚µ‚©‚µ’[‚ÅŠÏŽ@‚µ‚Ä‚¢‚镪‚É‚Í–Ê”’‚¢‚¯‚ê‚ǁA‚ ‚ ‚¢‚¤l‚½‚¿‚Æ‚Í‹^Ž—‰Æ‘°‚Æ‚µ‚Ă̈ӎ¯‚Ȃlj½‚à‚È‚©‚Á‚½‚킯‚ŁAŽ©•ª‚É‚à‚»‚ñ‚ÈŠ´î‚ª”ޏ—‚½‚¿‚ɑ΂µ‚Ä‚ ‚Á‚½‚Ì‚©‚µ‚ç‚ƁA‰ä‚ªg‚ð‚Ó‚è‚©‚¦‚Á‚Ä‚µ‚Ü‚Á‚½B‚»‚Ì‘¼‚É‚àAƒJƒ‰ƒIƒPA–Y”N‰ïAƒ‰ƒ“ƒLƒ“ƒOD‚«A¼‰¢ƒRƒ“ƒvƒŒƒbƒNƒXA“ú–{“Iƒ}ƒ]ƒqƒYƒ€‚Æ“ú–{“IƒTƒfƒBƒYƒ€A“ú–{‚ł͈ê‰ÆS’†‚Í‚æ‚­‚ ‚邪A¼‰¢‚É‚Í‚«‚í‚߂ď­‚È‚¢‚Æ‚©A“ú–{l‚ð“úí¶Šˆ‚©‚çlŽ@‚µ‚Ä‚ ‚éA‚Æ‚Ä‚à–Ê”’‚¢–{‚Å‚ ‚Á‚½Bv

---
posted by Fukutake at 08:06| “ú‹L

ˆãŠw‚͐l‚ɉ½‚ª‚Å‚«‚é‚©

uŽ€‚·‚ׂ«‚³‚¾‚߁v[Ž€‚É‚ä‚­l‚ɉ½‚ª‚Å‚«‚é‚©[@ƒAƒgƒD[ƒ‹EƒKƒƒ“ƒf
@Œ´ˆäG–¾ –ó@‚Ý‚·‚¸‘–[@‚Q‚O‚P‚U”N

Œµ‚µ‚¢‰ï˜b@p‚P‚W‚X`

@ucŠO‘‚𗷍s‚µ‚Ä‚¢‚é‚Æ‚«AƒEƒKƒ“ƒ_‚©‚ç—ˆ‚½“ñl‚̈ãŽt‚Æ“ìƒAƒtƒŠƒJ‚©‚ç—ˆ‚½ì‰Æ‚Ƙb‚µ‚½BƒTƒ‰‚̏Ǘá‚ɂ‚¢‚Äà–¾‚µA”ޏ—‚ɉ½‚ð‚·‚×‚«‚¾‚Á‚½‚ÆŽv‚¤‚©A”Þ‚ç‚̍l‚¦‚ðq‚Ë‚½B”Þ‚ç‚ÌŽ‹“_‚©‚ç‚·‚ê‚΁AƒTƒ‰‚ÉŽ¦‚µ‚½‘I‘ðŽˆ‚Í‹à‚Ì–³‘ÊŒ­‚¢‚ÉŒ©‚¦‚éB”Þ‚ç‚̍‘‚ł͏I––Šú‚ÌŠ³ŽÒ‚ª•a‰@‚É—ˆ‚邱‚Æ‚Í‚Ù‚Æ‚ñ‚Ç‚È‚¢‚ÆŒ¾‚¤B‚à‚µ—ˆ‚½‚Æ‚µ‚Ä‚à[@•a‹C‚Ì‹†‹É“I‚ÈŒ‹‰Ê‚ª‰Î‚ðŒ©‚é‚æ‚è–¾‚ç‚©‚ȏꍇ[@‹É’[‚È‘½Ü•¹—p‚É‚æ‚鉻Šw—Ö@‚âÅŒã‚ÌŽè’i‚Æ‚µ‚Ä‚ÌŠO‰ÈŽèpAŽÀŒ±“I‚ÈŽ¡—ÂðŽó‚¯‚邱‚Æ‚ðŠú‘Ò‚µ‚½‚èA‚»‚ê‚à‘Ï‚¦‚悤‚Æ‚·‚邱‚Æ‚Í‚È‚¢B‚»‚µ‚Ĉã—ÃVƒXƒeƒ€‚É‚Í”ï—p‚ð˜d‚¦‚邾‚¯‚ÌŽ‘‹à‚ª‚È‚¢B

@‚µ‚©‚µA‚»‚ÌŒã‚Ý‚È‚ªŽ©•ªŽ©g‚ÌŒoŒ±‚ðŒê‚è‚Í‚¶‚ß‚½B“à—e‚Í‚Ç‚±‚©‚Å•·‚¢‚½‚±‚Æ‚ª‚ ‚é‚à‚Ì‚¾‚Á‚½[@–{l‚̈ӎu‚É”½‚µ‚Ä‘c•ƒ•ê‚ª¶–½ˆÛŽ‘•’u‚ÉŒq‚ª‚ꂽAŽ¡—Õs”\‚ÌŠÌ‚ª‚ñ‚ɐN‚³‚ꂽeÊ‚ªŽÀŒ±“I‚ÈŽ¡—Â̂½‚ß‚É•a‰@‚Å–S‚­‚È‚Á‚½B––Šú‚Ì”]Žîᇂ̋`ŒZ‚ª‰»Šw—Ö@‚ð‰½ƒN[ƒ‹‚àŽó‚¯‚‚¯‚āAŽ¡—Ь‰Ê‚͏オ‚炸A‘Ì‚ð‰Õ‚Þ‚¾‚¯‚¾‚Á‚½‚ȂǁBuV‚µ‚¢ƒN[ƒ‹‚ðŒJ‚è•Ô‚·‚½‚сA‹`ŒZ‚Í‚»‚Ì‘O‚æ‚è‚à‚à‚Á‚ƔߎS‚ȏó‘Ô‚É‚È‚Á‚½vB“ìƒAƒtƒŠƒJ‚̍ì‰Æ‚ÍŒê‚Á‚½B

uˆãŠw‚Í‹`ŒZ‚Ì“÷‚ð‹ò‚Á‚Ä‚¢‚é‚ñ‚¾B‹`ŒZ‚ÌŽq‚Ç‚à‚½‚¿‚Í‚¢‚Ü‚¾‚É‚»‚Ì‚Æ‚«‚̃gƒ‰ƒEƒ}‚ð”w•‰‚Á‚Ä‚¢‚éB‹`ŒZ‚Í‚¸‚Á‚ƐÀ‚©‚¹‚Ä‚à‚炦‚È‚©‚Á‚½Bv

uHard Conversation
Traveling abroad sometime afterward, I fell into a conversation with two doctors from Uganda and a writer from South Africa. I told them about Sara's case and asked what they thought should have been done for her. To their eyes, the choices we offered her seemed extravagant. Most people with terminal illness in their countries would never have come to the hospital, they said. Those who did would neither expect nor tolerate the extremes of multiple chemotherapy regimens, last-ditch surgical procedures, experimental therapies- when the problem's ultimate outcome was so dismally clear. And the health system wouldn't have the money for it.

But then they couldn't help but talk about their own experiences, and their tales sounded familiar: a grandparent put on life support against his wishes, a relative with incurable liver cancer who died in the hospital on an experimental treatment, a brother-in-law with a terminal brain tumor who nonetheless endured endless cycle of chemotherapy that had no effect except to cut him down further and further.

"Each round was more horrible than the last," the South African writer told me. "I saw the medicine eat his flesh. The children are still traumatized. He could never let go."v

(Atul Gawande "BeingMortal" Medicine and what Matters in the End)

----
I––Š³ŽÒ‚ð‹s‘Ò‚·‚éˆã—Ã



posted by Fukutake at 08:01| “ú‹L